After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Arrowhead Pharmaceuticals Inc is $1.69B. A total of 1.44 million shares were traded on the day, compared to an average of 2.04M shares.
In the most recent transaction, Anzalone Christopher Richard sold 50,800 shares of ARWR for 11.49 per share on Apr 11 ’25. After the transaction, the Chief Executive Officer now owns 3,921,255 company shares. In a previous transaction on Apr 10 ’25, Anzalone Christopher Richard sold 50,000 shares at 10.87 per share. ARWR shares that Chief Executive Officer owns now total 3,972,055.
Among the insiders who sold shares, Anzalone Christopher Richard disposed of 40,322 shares on Apr 09 ’25 at a per-share price of $10.07. This resulted in the Chief Executive Officer holding 4,022,055 shares of ARWR after the transaction. In another insider transaction, Anzalone Christopher Richard bought 50,800 shares at $11.49 per share on Apr 11 ’25.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ARWR has a high of $30.41 and a low of $9.57.
As of this writing, ARWR has an earnings estimate of -$0.46 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of $2.69 per share and a lower estimate of -$1.37.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ARWR’s latest balance sheet shows that the firm has $367.79M in Cash & Short Term Investments as of fiscal 2021. There were $25.55M in debt and $146.54M in liabilities at the time. Its Book Value Per Share was $0.42, while its Total Shareholder’s Equity was $408.82M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARWR is Buy with a score of 4.27.
